Latest Breaking News On - Bio pharma stock down - Page 1 : comparemela.com

Brokerages Set BridgeBio Pharma, Inc. (NASDAQ:BBIO) Target Price at $47.82

Brokerages Set BridgeBio Pharma, Inc. (NASDAQ:BBIO) Target Price at $47.82
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Bio pharmaBridgebio pharmaRandalw scottRaymond jamesCampbell co investment adviserMoody aldrich partnersManufacturers life insurance companyJpmorgan chase coPrimecap management coCantor fitzgeraldBridgebio pharma company profileBridgebio pharma incBoone capital managementBio pharma incGet free reportDirector randal

Duality Advisers LP Buys 31,036 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)

Duality Advisers LP Buys 31,036 Shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Raymond jamesRandalw scottBio pharmaChina universal asset management coXponance incJpmorgan chase coBio pharma incSecurities exchange commissionHealthcare of ontario pension plan trust fundAssetmark incCantor fitzgeraldExchange commissionBridgebio pharma incDuality advisersBridgebio pharmaFree report

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives $42.00 Average Price Target from Brokerages

BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives $42.00 Average Price Target from Brokerages
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

New zealand generalNew zealandBio pharmaHannah valantineFrank mccormickBridgebio pharmaBridgebio pharma incBio pharma incWellington management groupGeode capital managementPerceptive advisorsCantor fitzgeraldWells fargo companyVanguard group incGet free reportMarketbeat ratings

Insider Selling: BridgeBio Pharma, Inc. (NASDAQ:BBIO) Director Sells 2,000 Shares of Stock

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) Director Randal W. Scott sold 2,000 shares of BridgeBio Pharma stock in a transaction dated Monday, December 18th. The shares were sold at an average price of $40.00, for a total value of $80,000.00. Following the completion of the transaction, the director now owns 9,000 shares of […]

Randalw scottBio pharmaBridgebio pharma incCantor fitzgeraldCovestor ltdBridgebio pharma company profileAssetmark incWells fargo companyBio pharma incBridgebio pharmaGet free reportDirector randalBio pharma stock downStreet marketsSandia investment managementBridgebio pharma daily

Natixis Trims Stock Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)

Natixis Trims Stock Position in BridgeBio Pharma, Inc. (NASDAQ:BBIO)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Bio pharmaBridgebio pharmaNatixi bio pharmaQuantamental technologiesCantor fitzgeraldBridgebio pharma incBridgebio pharma company profileBio pharma incCovestor ltdJpmorgan chase coFree reportStreet marketsInvestment managementBio pharma stock downGet free reportVisit holdingschannel